Medicated Shampoo Global Market Report 2025

The medicated shampoo market size has grown strongly in recent years. It will grow from$13.14 billion in 2024 to $13.89 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to factors such as a rise in skin and scalp conditions, increased awareness of personal hygiene, growing urbanization, a rise in allergies and sensitivities, and a growing demand for eco-friendly and organic products.

The medicated shampoo market size is expected to see strong growth in the next few years. It will grow to$17.12 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth during the forecast period can be attributed to factors such as the expansion of e-commerce channels, a rising incidence of scalp infections, increasing demand for dermatologist-recommended products, a shift towards natural and herbal ingredients, and regulatory support and standardization. Key trends in the forecast period include innovations in dermatological treatments, integration with hair wellness technology, advancements in product formulations, increased customization and personalization, and the emergence of crossover products that combine hair care with supplements.

The increasing prevalence of scalp disorders is expected to drive the growth of the medicated shampoo market. Scalp disorders encompass a range of conditions that affect the skin on the scalp, often leading to symptoms such as itching, flaking, inflammation, and hair loss. The rising levels of pollution are contributing to the growing prevalence of these conditions, as pollution irritates the scalp and disrupts its natural barrier, triggering problems such as dandruff and seborrheic dermatitis. Medicated shampoos are specifically formulated to address these issues by containing active ingredients that target the root causes of scalp disorders, such as fungi or inflammation, to alleviate symptoms and promote healing. For example, in February 2025, the American Academy of Dermatology Association reported that acne is the most prevalent skin condition in the United States, affecting around 50 million individuals annually. Additionally, approximately 85% of people aged 12 to 24 experience at least mild forms of acne, which can also influence scalp health. Thus, the rising prevalence of scalp disorders is fueling the growth of the medicated shampoo market.

Leading companies in the medicated shampoo market are focusing on developing innovative products, such as medicated dry shampoos, to meet the growing demand for convenient and effective scalp care solutions. Medicated dry shampoos combine the oil-absorbing properties of traditional dry shampoos with active ingredients to treat scalp conditions such as dandruff and seborrheic dermatitis. For example, in November 2024, Raven Innovations LLC, a U.S.-based pharmaceutical and personal care company, introduced RestoraScalp, the world’s first medicated dry shampoo designed to treat scalp conditions such as dandruff, seborrheic dermatitis, and psoriasis. This breakthrough product features salicylic acid 2% as its active ingredient, along with natural extracts such as chamomile, olive leaf, and green tea, known for their soothing and oil-absorbing properties. RestoraScalp is vegan, cruelty-free, and fragrance-free, making it suitable for all skin types. It can be applied directly to the scalp on non-wash days, offering a convenient, water-free solution for effective scalp care.

In April 2022, Wella Company, a Switzerland-based global hair care leader, acquired Briogeo for an undisclosed amount. The acquisition allows Wella to enhance its market position by expanding its customer base, incorporating new technologies and expertise, achieving operational synergies, and diversifying its product offerings. Briogeo, a U.S.-based brand known for its natural hair care products, offers a range of medicated shampoos designed to address various scalp concerns, further bolstering Wella’s commitment to innovation and growth in the hair care market.

Major players in the medicated shampoo market are Johnson & Johnson, The Procter & Gamble Company, Unilever PLC, Kao Corporation, Cipla Limited, The Himalaya Company, Radius Health Inc., Avalon Natural Products Inc., Ederma Pharma India Private Limited, Elegant Cosmed Private Limited, Luxica Pharma Inc., Yaxon Biocare Pvt. Ltd., Art Naturals Inc., Nioxin Research Laboratories Inc., Sulfur 8 Inc., Summer Laboratories Inc., Mars Medisoap Private Limited, Staple Pharmaceuticals Pvt. Ltd., Astonea Labs Limited, Ketopoz Pharmaceuticals Pvt. Ltd., and Maylizz Biotech Private Limited.

North America was the largest region in the medicated shampoo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medicated shampoo report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medicated shampoo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medicated shampoo is a type of shampoo specifically formulated to treat various scalp and hair conditions by delivering medicinal ingredients directly to the scalp. These shampoos contain therapeutic substances or drugs that target issues such as dandruff, psoriasis, seborrheic dermatitis, fungal infections, and other scalp-related conditions.

The main categories of medicated shampoos include those designed for dandruff, baldness, scalp issues, and hair loss. Dandruff is a scalp condition characterized by skin flaking on the scalp, often accompanied by itching. These shampoos provide treatments for conditions such as dandruff, seborrheic dermatitis, psoriasis, tinea capitis, head lice, and allergic reactions. They are distributed through various channels such as supermarkets, hypermarkets, pharmacies, drugstores, department stores, online platforms, and others.

The medicated shampoos market research report is one of a series of new reports that provides medicated shampoos market statistics, including medicated shampoos industry global market size, regional shares, competitors with a medicated shampoos market share, detailed medicated shampoos market segments, market trends and opportunities, and any further data you may need to thrive in the medicated shampoos industry. This medicated shampoo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medicated shampoo market consists of sales of anti-dandruff shampoos, anti-itch shampoos, psoriasis shampoos, oily scalp shampoos, and scalp infection shampoos. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.